AN2 Therapeutics, Inc. Common Stock (ANTX) is a publicly traded Healthcare sector company. As of September 9, 2026, ANTX trades at $5.97 with a market cap of $222.27M and a P/E ratio of -3.50. ANTX moved +1.44% today. Year to date, ANTX is +424.56%; over the trailing twelve months it is +402.52%. Its 52-week range spans $1.00 to $7.19. Analyst consensus is buy with an average price target of $9.00. Rallies surfaces ANTX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for ANTX, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $5.97 |
| Market Cap | $222.27M |
| P/E Ratio | -3.50 |
| EPS | $-1.72 |
| Dividend Yield | 0.66% |
| 52-Week High | $7.19 |
| 52-Week Low | $1.00 |
| Volume | 324.05K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-51.32M |
| Gross Margin | 0.00% |
1 analysts cover ANTX: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $9.00.